Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-050601

HERON THERAPEUTICS, INC. /DE/ · HRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Sep 12, 2018
Accepted (ET)
Sep 12, 2018 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 12, 2018S2,695,000$35.75D5,830,215IBy LP
Common StockF3holding———14,347IAs Trustee
Common StockF4holding———6,941D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses